Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹46 Cr.
Stock P/E
18.3
P/B
1.1
Current Price
₹1.2
Book Value
₹ 1.1
Face Value
1
52W High
₹1.3
52W Low
₹ 0.5
Dividend Yield
0%

Tavexia Lifecare Overview

Business

Sattva Sukun Lifecare Ltd. operates in the Trading sector in India. As a trading company, its core business model involves buying goods or commodities and reselling them, aiming to profit from the difference between purchase and sale prices (the margin). Given "Lifecare" in its name, it is plausible, though not confirmed, that the company specializes in trading products related to healthcare, pharmaceuticals, medical equipment, or general wellness. The company generates revenue through sales of these traded goods and makes profit on the margins achieved.

Revenue Mix

Information regarding specific business segments, product categories, or their respective revenue contributions is not available.

Industry

The trading industry in India is generally fragmented and competitive, characterized by low barriers to entry. Profitability often depends on efficient supply chain management, strong vendor and customer relationships, and the ability to manage inventory and market price fluctuations effectively. Without specific market share data or details on the products traded, Sattva Sukun Lifecare Ltd.'s precise positioning relative to its peers is unknown. It likely competes with numerous other trading firms, both large and small.

MOAT

Based on the limited information, it is difficult to identify a strong, sustainable competitive advantage for Sattva Sukun Lifecare Ltd. General trading businesses often struggle to build durable moats unless they possess unique supply agreements, proprietary technology for logistics, significant scale that allows for cost leadership, or operate in highly specialized niches with strong relationships or regulatory hurdles. For a generic trading company, competitive advantages are typically weak, relying more on operational efficiency and market responsiveness.

Growth Drivers

Potential growth drivers for a trading company like Sattva Sukun Lifecare Ltd. could include:

Overall economic growth in India, leading to increased demand for traded goods.

Expansion into new product categories or geographical markets.

Developing stronger distribution networks and vendor relationships.

Improved operational efficiency, leading to better margins.

Favorable government policies or increased public spending in the healthcare sector (if its focus is indeed lifecare products).

Risks

Key risks for Sattva Sukun Lifecare Ltd. include:

Intense Competition: The trading sector is highly competitive, leading to potential margin compression.

Price Volatility: Fluctuations in the purchase or selling prices of traded goods can significantly impact profitability.

Inventory Risk: Holding inventory carries the risk of obsolescence, damage, or decline in market value.

Supply Chain Disruptions: Issues with sourcing, logistics, or transportation can affect operations and profitability.

Credit Risk: Reliance on credit terms with suppliers and customers can expose the company to default risks.

Regulatory Changes: Changes in trade policies, import/export duties, or sector-specific regulations (e.g., healthcare products) could impact the business.

Economic Slowdown: A general economic downturn would likely reduce demand for traded goods, affecting sales volumes.

Management & Ownership

Specific details about the promoters, management team's experience, or the ownership structure of Sattva Sukun Lifecare Ltd. are not publicly available based on the provided data. In India, many companies, especially in this sector, are often promoter-driven, where the founding family or individuals maintain significant ownership and control.

Outlook

Assessing the specific outlook for Sattva Sukun Lifecare Ltd. is challenging due to the limited information available. Generally, trading companies operate in a high-volume, low-margin environment.

Bull Case: If the company can efficiently manage its supply chain, secure favorable procurement terms, adapt to market demands, and potentially carve out a niche in the "lifecare" segment with strong relationships, it could achieve consistent growth in volumes and maintain healthy margins. Expanding into high-demand products or new territories could also be a growth avenue.

Bear Case: The company faces significant headwinds from intense competition, potential margin erosion, and exposure to economic cycles and commodity price fluctuations. Inefficient inventory management, poor credit control, or an inability to differentiate itself could lead to stagnant growth or declining profitability. The lack of identifiable competitive advantages could make it vulnerable in a crowded market.

Tavexia Lifecare Share Price

Live · BSE · Inception: 1980
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Tavexia Lifecare Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 1 1 2 2 1 1 17 6 9 1
Other Income 0 0 0 0 0 0 0 0 6 0
Total Income 1 1 2 2 1 1 17 6 14 1
Total Expenditure 0 0 1 1 0 0 16 6 15 1
Operating Profit 1 1 1 1 1 1 1 -1 -1 -0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 0 1 1 1 1 1 -1 -1 -0
Provision for Tax 0 0 0 0 0 0 0 -0 -0 -0
Profit After Tax 0 0 1 1 1 1 1 -1 -1 -0
Adjustments 0 -0 0 -0 0 -0 -0 0 0 0
Profit After Adjustments 0 0 1 1 1 1 1 -1 -0 -0
Adjusted Earnings Per Share 0 0 0 0 0 0 0 -0 -0 -0

Tavexia Lifecare Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 0 1 2 2 4 5 33
Other Income 0 2 0 0 0 0 6
Total Income 0 3 2 2 4 6 38
Total Expenditure 0 3 1 1 2 2 38
Operating Profit -0 0 0 1 2 4 -1
Interest 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0
Profit Before Tax -0 0 0 1 2 3 -1
Provision for Tax 0 0 0 0 0 1 0
Profit After Tax -0 0 0 1 1 2 -1
Adjustments 0 0 0 0 0 0 0
Profit After Adjustments -0 0 0 1 1 2 0
Adjusted Earnings Per Share -0 0 0 0 0.1 0.1 0

Tavexia Lifecare Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 1 4 4 15 22 24
Minority's Interest 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 -0 -0
Total Current Liabilities 0 1 1 1 1 2
Total Liabilities 1 4 4 16 23 26
Fixed Assets 0 0 0 2 1 1
Other Non-Current Assets 1 0 0 8 11 11
Total Current Assets 0 4 4 7 11 14
Total Assets 1 4 4 16 23 26

Tavexia Lifecare Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 0
Cash Flow from Operating Activities -0 -0 -1 -1 -3 0
Cash Flow from Investing Activities -0 0 1 -10 -3 -0
Cash Flow from Financing Activities 0 0 0 11 6 0
Net Cash Inflow / Outflow -0 0 -0 0 -0 -0
Closing Cash & Cash Equivalent 0 0 0 0 0 0

Tavexia Lifecare Ratios

# Mar 2014 Mar 2015 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -0 0 0 0.04 0.05 0.11
CEPS(Rs) -0 0.01 0.01 0.06 0.07 0.13
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) 1.91 0.59 0.6 0.86 0.94 1.05
Core EBITDA Margin(%) 0 -138.9 9.74 45.34 54.99 61.92
EBIT Margin(%) 0 1.3 5.84 39.88 44.61 61.54
Pre Tax Margin(%) 0 1.28 1.95 35.89 43.13 60.55
PAT Margin (%) 0 0.16 1.3 25.01 33.5 47.3
Cash Profit Margin (%) 0 0.16 5.19 35.08 44.32 55.36
ROA(%) -0.04 0.09 0.45 5.32 6.01 10.01
ROE(%) -0.04 0.1 0.55 6.63 6.87 10.94
ROCE(%) -0.02 0.81 2.42 9.04 8.32 13.83
Receivable days 0 126.1 284.38 407.92 410.52 365.18
Inventory Days 0 84.97 178.53 278.45 262.35 300.05
Payable days 0 12.55 96.95 418.24 150.88 371.97
PER(x) 0 0 352.96 29.63 22.76 8.41
Price/Book(x) 0 0 1.93 1.26 1.25 0.88
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) 0 2.03 4.61 7.49 7.65 4.07
EV/Core EBITDA(x) -824.95 156.04 47.33 14.99 13.81 5.85
Net Sales Growth(%) 0 0 13.28 43.69 60.58 48.12
EBIT Growth(%) 0 0 409.39 880.44 79.65 104.3
PAT Growth(%) 0 920.51 792.54 2667.5 115.07 109.13
EPS Growth(%) 0 151.09 792.86 1006.88 43.27 109.23
Debt/Equity(x) 0 0 0.03 0.02 0.01 0.02
Current Ratio(x) 45.78 5.6 5.77 8.02 10.33 6.43
Quick Ratio(x) 45.78 5.16 4.16 5.41 7.65 3.87
Interest Cover(x) -7.76 64.72 1.5 9.99 30.02 62.64
Total Debt/Mcap(x) 0 0 0.01 0.01 0.01 0.02

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +25% +36% — —
Operating Profit CAGR +100% — — —
PAT CAGR +100% — — —
Share Price CAGR +47% -5% -24% —
ROE Average +11% +8% +5% +4%
ROCE Average +14% +10% +7% +6%

Tavexia Lifecare Shareholding Pattern

Latest · Sep 2026
100% held
Promoters 3.65 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 96.35 %
# Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Promoter 3.113.113.633.623.626.46.46.396.393.65
FII 0000000000
DII 0000000000
Public 96.8996.8996.3796.3896.3893.693.693.6193.6196.35
Others 0000000000
Total 100100100100100100100100100100

Tavexia Lifecare Peer Comparison

Tavexia Lifecare Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Tavexia Lifecare Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 3.65%.
  • Company has a low return on equity of 8% over the last 3 years.
  • Debtor days have increased from 150.88 to 371.97days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp